Homebiotech

biotech

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026

biotech

New approach to treating chronic wounds

Jim Cornall - October 7, 2026

biotech

Hidden amplification switch has implications for cancer metastasis

Jim Cornall - October 7, 2026

biotech

Recreating key features of the antibody factory in a dish

Jim Cornall - October 7, 2026

biotech

Walks to support Lennox-Gastaut syndrome research

Jim Cornall - April 13, 2026

biotech

Precision nanomedicine to target most challenging tumours

Jim Cornall - April 13, 2026

biotech

Base to Base biotech podcast 54: Parkinson’s disease and peptides

Jim Cornall - April 10, 2026

biotech

Study shows prostate cancer can be detected through urine-based liquid biopsy

Jim Cornall - April 9, 2026

biotech

Cyclerion and Korsana announce merger

Jim Cornall - April 9, 2026

biotech

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall - April 9, 2026

biotech

Positive results from moderate-to-severe atopic dermatitis trial

Jim Cornall - April 8, 2026

biotech

Centessa Pharmaceuticals to be acquired by Lilly

Jim Cornall - April 8, 2026

1...353637...104 Page 36 of 104

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

How cells fight back after bacterial toxins break through

Jim Cornall - October 8, 2026 0

Bacterial toxins can create pores in epithelial cell membranes, threatening cell survival and weakening the body’s protective barriers. Yet when these barriers are breached,...

New approach to treating chronic wounds

biotech Jim Cornall - October 7, 2026 0

Hidden amplification switch has implications for cancer metastasis

biotech Jim Cornall - October 7, 2026 0

Recreating key features of the antibody factory in a dish

biotech Jim Cornall - October 7, 2026 0

FDA Orphan Drug Designation and Rare Pediatric Disease Designation for sarcoma drug

biotech Jim Cornall - October 6, 2026 0